Literature DB >> 2012375

Serum alkaline phosphatase isoenzymes as markers of liver disease.

S Narayanan1.   

Abstract

A perspective on serum alkaline phosphatase isoenzymes in liver disease is provided with a brief discussion of the location of the enzyme in liver and its presumed function. Mechanisms of entry of alkaline phosphatase into serum in liver disease are discussed. Characterization of high molecular weight alkaline phosphatase in obstructive jaundice is reviewed. The relationship between blood group O and the appearance of the intestinal enzyme in sera of such subjects with cirrhosis of liver is discussed. Properties of hepatoma alkaline phosphatase and the genesis of liver alkaline phosphatase in diseases not related to the liver are explored. Methods for detection of serum alkaline phosphatase isoenzymes in liver disease are discussed from the standpoint of the limitations of electrophoretic procedures, and the promise of procedures such as isoelectric focusing and high performance liquid chromatography that are currently non-routine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012375

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  3 in total

1.  Liver Function Enzymes are Potential Predictive Markers for Kidney Allograft Dysfunction.

Authors:  Alakesh Bera; Eric Russ; Rahul M Jindal; Maura A Watson; Robert Nee; Ofer Eidelman; John Karaian; Harvey B Pollard; Meera Srivastava
Journal:  Adv J Urol Nephrol       Date:  2020-03-03

Review 2.  A new perspective on the function of Tissue Non-Specific Alkaline Phosphatase: from bone mineralization to intra-cellular lipid accumulation.

Authors:  Cara-Lesley Bartlett; Eleanor Margaret Cave; Nigel John Crowther; William Frank Ferris
Journal:  Mol Cell Biochem       Date:  2022-04-26       Impact factor: 3.396

3.  Probable levetiracetam-related serum alkaline phosphatase elevation.

Authors:  Nian Xiong; Lingling Hou; Na Lu; Asrah A Mohamed; Tao Wang; Yaling Huang
Journal:  BMC Neurol       Date:  2012-09-20       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.